Using special foam to stop severe bleeding in traumatic injuries
Shape Memory Polymer Foams for Hemorrhage Control in Traumatic Wounds
This study is testing a new foam that can help stop bleeding from serious injuries, making it easier for anyone to use in emergencies, especially in places far from hospitals.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Syracuse University NIH-funded |
| Lab location | 1 site (Syracuse, United States) |
| Project ID | NIH-11093441 on NIH RePORTER |
What this research studies
This research focuses on developing a new type of foam made from shape memory polymers that can effectively control bleeding in traumatic wounds. The approach involves testing this foam in models that simulate real-life injuries to determine how well it can stop hemorrhaging. The goal is to create a product that is easy to use, requires minimal training, and can be applied in emergency situations, especially in remote areas. By improving the materials used for hemorrhage control, the research aims to reduce deaths caused by uncontrolled bleeding before patients reach medical facilities.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals who have experienced traumatic injuries that result in severe bleeding.
Not a fit: Patients with non-traumatic conditions or those who do not experience significant hemorrhage may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could provide a life-saving tool for managing severe bleeding in trauma patients.
How similar studies have performed: Preliminary studies have shown promising results with similar materials, indicating potential for success in this novel approach.
Where this research is happening
Syracuse, United States
- Syracuse University — Syracuse, United States (Active)
Researchers
- Principal investigator: Monroe, Mary Beth — Syracuse University
- Study coordinator: Monroe, Mary Beth
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.